Trials / Completed
CompletedNCT01352897
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects With Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2011-05-12
- Last updated
- 2011-05-12
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT01352897. Inclusion in this directory is not an endorsement.